Board of Directors

Anja Harmeier is the head of Roche Venture Fund and combines deep R&D leadership with a strong venture track record.

Former CEO of Rewind Therapeutics and Partner at Pureos Bioventures, her investments include Corlieve (acq. uniQure), Entrada (IPO), NMD Pharma, and Vivet (Pfizer option).

Previously, Anja spent almost 10 years at F.Hoffmann-La Roche across Neuroscience R&D and as an Investment Director at RVF.

She holds a PhD in Neuroscience and an MBA.